Efficacy of azelaic acid 20% versus anthralin 1% in scalp alopecia areata

Efficacy of azelaic acid 20% versus anthralin 1% in patients with scalp alopecia areata

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002581N8

Enrollment

Registered

2022-06-29

Start date

2022-07-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia areata. Alopecia areata

Interventions

Intervention 1: Intervention group: Anthralin 1% treatment group (dissolved in Vaseline) The treatment will start with the use for 10 minutes a day. In order to cause mild inflammation, the duration o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having alopecia areata scalp Not receiving treatment during the previous month Consent for the study

Exclusion criteria

Exclusion criteria: Pregnant women Receiving effective treatments for alopecia areata taking corticosteroids and immunosuppressants and immunomodulators during the past month Alopecia areata in a location other than the scalp and Alopecia areata universalis

Design outcomes

Primary

Measure	Time frame
Patient recovery rate. Timepoint: Every month after intervention for 6 months. Method of measurement: Clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamideh Herizchi Ghadim

Tabriz University of Medical Sciences

dr.herizchi@yahoo.com+98 41 1540 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026